Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (Q167209): Difference between revisions

From geokb
(‎Changed an Item: moved OpenAlex ID to its dedicated external ID datatype for consistency)
(‎Changed label, description and/or aliases in en, and other parts: removed aliases from OpenAlex keywords)
 
aliases / en / 0aliases / en / 0
Chronic Lymphocytic Leukemia
aliases / en / 1aliases / en / 1
Genomic Aberrations
aliases / en / 2aliases / en / 2
BTK Inhibitors
aliases / en / 3aliases / en / 3
Rituximab
aliases / en / 4aliases / en / 4
Ibrutinib
aliases / en / 5aliases / en / 5
Prognostic Factors
aliases / en / 6aliases / en / 6
TP53 Mutation
aliases / en / 7aliases / en / 7
Waldenström Macroglobulinemia
aliases / en / 8aliases / en / 8
Immunoglobulin Mutation
aliases / en / 9aliases / en / 9
Therapeutic Targets

Latest revision as of 21:11, 12 September 2024

Study of CLL's genetic mutations and treatment options.
Language Label Description Also known as
English
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
Study of CLL's genetic mutations and treatment options.

    Statements

    0 references
    0 references